From Name

From Email

To Name

To Email

Message

CMS proposed rule aims to foster more Medicaid value-based drug agreements

from Fierce Healthcare

CMS proposed rule aims to foster more Medicaid value-based drug agreements Fierce Healthcare The Trump administration issued a proposed rule intended to remove barriers to develop value-based purchasing agreements between states and drug companies. The Centers for Medicare & Medicaid Services’ final rule gives states more flexibility to enter into value-based purchasing agreements with drugmakers for new and pricey products. READ MORE

more